Stephanie Frank
About Stephanie Frank
Stephanie Frank is a Quality Control Analytical Senior Specialist at Adaptimmune, specializing in assay validations for cell therapy drug products. She has over eight years of experience in laboratory analytics and holds a Master's degree in Biology from the University of Saint Joseph.
Work at Adaptimmune
Stephanie Frank has been employed at Adaptimmune since 2020, serving as a Quality Control Analytical Senior Specialist. In this role, she specializes in assay validations for cell therapy drug products. Her responsibilities include ensuring compliance with FDA regulations and industry guidelines. She drafts and presents validation data and reports to clinical and development teams, contributing to the overall quality assurance processes within the organization.
Education and Expertise
Stephanie Frank holds a Master's degree in Biology from the University of Saint Joseph, which she obtained from 2015 to 2018. Prior to that, she earned a Bachelor of Science in Biology from Norwich University, completing her studies from 2008 to 2012. Her educational background supports her expertise in laboratory analytics, particularly in the healthcare and biological sciences sectors.
Background
Stephanie Frank has over 8 years of focused experience in laboratory analytics. Her career includes roles at various organizations, including BioReference Laboratories, where she worked as a Medical Technologist from 2012 to 2017, and Talaris Therapeutics, where she served as a Quality Control Specialist from 2019 to 2020. She also worked at LabCorp as a Pathology Grosser for 10 months in 2018 to 2019.
Achievements
Throughout her career, Stephanie Frank has developed a strong foundation in quality control and analytical processes. Her work in assay validations and compliance with regulatory standards reflects her commitment to maintaining high-quality laboratory practices. She has effectively communicated validation data and reports to various stakeholders, enhancing collaboration between clinical and development groups.